Fundies.
English

Segment disclosures

Company overview

Immunome, Inc.

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 14 retained observations 9 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Single Reportable Segment

Statement Business Segments

Multiple units reported for the same period; values are kept separate.

Source dimensions us-gaap:StatementBusinessSegmentsAxis=imnm:SingleReportableSegmentMember
PeriodValueUnitFiledEvidence
2025-01-01 – 2025-12-316941000 USD20260303Open filing evidence
2025-01-01 – 2025-09-306941000 USD20251106Open filing evidence
2025-04-01 – 2025-06-304015000 USD20260811Open filing evidence
2025-01-01 – 2025-06-306941000 USD20260811Open filing evidence
2025-01-01 – 2025-03-312926000 Unit_Standard_USD_Zthd78fMFEil_djxp9TnUQ20250512Open filing evidence
2025-01-01 – 2025-03-312926000 USD20260512Open filing evidence
2024-01-01 – 2024-12-319041000 Unit_Standard_USD_O4jAAS37FEWJem3yF-6iAw20250319Open filing evidence
2024-01-01 – 2024-12-319041000 USD20260303Open filing evidence
2024-07-01 – 2024-09-302910000 USD20251106Open filing evidence
2024-01-01 – 2024-09-306303000 USD20251106Open filing evidence
2024-04-01 – 2024-06-302364000 USD20250806Open filing evidence
2024-01-01 – 2024-06-303393000 USD20250806Open filing evidence
2024-01-01 – 2024-03-311029000 Unit_Standard_USD_Zthd78fMFEil_djxp9TnUQ20250512Open filing evidence
2023-01-01 – 2023-12-3114018000 Unit_Standard_USD_O4jAAS37FEWJem3yF-6iAw20250319Open filing evidence